Study: Combo slows tumors in mice with breast cancer

08/12/2008 | Google

Researchers at the University of Sheffield in the U.K. reported that treatment with doxorubicin -- a chemotherapy agent -- and zoledronic acid -- a bisphosphonate drug -- impeded tumor growth in mice with breast cancer. In the study, doxorubicin appeared to make the tumor sensitive to bisphosphonate, triggering apoptosis and blocking angiogenesis.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD